Clinical Trial

Study to Evaluate the Efficacy of Intravenous Administration of Human Albumin Versus Saline Solution in Patients With descompénsate Cirrhosis Grade 1B or Higher Renal Failure

Study acronym: LIVER-AKI
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This is a phase IV, unicentric, open-label. Patients eligible for this study will be patients with AKI 1B or greater and decompensated cirrhosis from the hospital participating in the study
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-26.
Trial Details
NCT Number NCT07270874
Lead Sponsor Fundacion Clinic per a la Recerca Biomédica
Conditions Decompensated Cirrhosis, AKI - Acute Kidney Injury
Enrollment 114 participants
Start Date 2026-01
Primary Completion 2027-08 (estimated)
Study Completion 2028-02 (estimated)
Updated on ClinicalTrials.gov 2025-12-18